Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsHealth Care BIO Events BIO EVENT Industry Analysis public policy health Food biotech industry Plant biotechnology GMOs global food crisis Sustainability BIO Investor Forum patent FDA healthcare USPTO BIOTECH biotechnology Intellectual Property
- Most Popular
Latest VideoJohn Chambers, Vice Chairman, Head of Healthcare Investment Banking, ROTH Capital Partners View All >